The Hindu Business Line : MHRA clears Strides plant

Advertisement

Bangalore Feb. 19 Strides Arcolab has said its Bangalore plant for sterile products has received the approval of the UK MHRA (Medicines and Healthcare products Regulatory Agency). The plant makes sterile non-penicillin and non-cephalosporins.

Mr Arun Kumar, Vice-Chairman and MD, said, "The MHRA approval of the Sterile Products Division is an important milestone in the company's European market strategy. The facility has also received approval from the Therapeutic Goods Administration (TGA), Australia, Health Products and Food Branch Inspectorate, Canada, and Anvisa, Brazil."

Strides has 14 manufacturing plants spread across India, the US, Brazil, Mexico, Italy, Poland and Singapore.

More Stories on : Standards & Benchmarks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Major fire at Cadila Pharma

L&T bags contract worth $250 m

Tata Tea to divest stake in northern operations

MTL may be merged with Falcon with retrospective effect

Vectra to buy out remaining 8% in Tatra

Suprajit to set up cable unit in Singur

Ceat plans to set up truck radial facility

Indian power cos flock to Africa, Middle East

DGH disallows ONGC's gas discovery in KG basin

Chetra Industrial plans joint ventures in India

Chevron chief visiting India

`Punish cos for Clause 49 non-compliance'

MHRA clears Strides plant

Public sector units revamp board may come under PMO

Hatsun Agro targets 4,000 `pure' dairy farms

Small car: Ford to leverage emerging markets resources